Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
5.27
-0.79 (-13.04%)
At close: Oct 27, 2025, 4:00 PM EDT
5.03
-0.24 (-4.55%)
After-hours: Oct 27, 2025, 6:40 PM EDT
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $190.93 million as of October 27, 2025. Its market cap has increased by 133.41% in one year.
Market Cap
190.93M
Enterprise Value
333.09M
1-Year Change
133.41%
Ranking
Category
Stock Price
$5.27
Market Cap Chart
Since December 1, 1998, Armata Pharmaceuticals's market cap has increased from $49.80M to $190.93M, an increase of 283.40%. That is a compound annual growth rate of 5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 219.60M | 228.25% |
| Dec 31, 2024 | 66.90M | -42.87% |
| Dec 29, 2023 | 117.10M | 161.38% |
| Dec 30, 2022 | 44.80M | -69.81% |
| Dec 31, 2021 | 148.40M | 165.95% |
| Dec 31, 2020 | 55.80M | 72.76% |
| Dec 31, 2019 | 32.30M | 375.00% |
| Dec 31, 2018 | 6.80M | -29.17% |
| Dec 29, 2017 | 9.60M | 95.92% |
| Dec 30, 2016 | 4.90M | -79.06% |
| Dec 31, 2015 | 23.40M | -40.46% |
| Dec 31, 2014 | 39.30M | 281.55% |
| Dec 31, 2013 | 10.30M | 178.38% |
| Dec 31, 2012 | 3.70M | 60.87% |
| Dec 30, 2011 | 2.30M | -68.92% |
| Dec 31, 2010 | 7.40M | 27.59% |
| Dec 31, 2009 | 5.80M | 31.82% |
| Dec 31, 2008 | 4.40M | -85.57% |
| Dec 31, 2007 | 30.50M | -47.86% |
| Dec 29, 2006 | 58.50M | 39.62% |
| Dec 30, 2005 | 41.90M | -66.88% |
| Dec 31, 2004 | 126.50M | -12.76% |
| Dec 31, 2003 | 145.00M | 621.39% |
| Dec 31, 2002 | 20.10M | -83.21% |
| Dec 31, 2001 | 119.70M | -58.35% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |